Molecular concepts analysis links tumors, pathways, mechanisms, and drugs

被引:109
作者
Rhodes, Daniel R.
Kalyana-Sundaram, Shanker
Tomlins, Scott A.
Mahavisno, Vasudeva
Kasper, Nicole
Varambally, Radhika
Barrette, Terrence R.
Ghosh, Debashis
Varambally, Sooryanarayana
Chinnaiyan, Arul M.
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
来源
NEOPLASIA | 2007年 / 9卷 / 05期
关键词
cancer; bioinformatics; gene expression signature; network; oncomine;
D O I
10.1593/neo.07292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Global molecular profiling of cancers has shown broad utility in delineating pathways and processes underlying disease, in predicting prognosis and response to therapy, and in suggesting novel treatments. To gain further insights from such data, we have integrated and analyzed a comprehensive collection of "molecular concepts'' representing > 2500 cancer- related gene expression signatures from Oncomine and manual curation of the literature, drug treatment signatures from the Connectivity Map, target gene sets from genome- scale regulatory motif analyses, and reference gene sets from several gene and protein annotation databases. We computed pairwise association analysis on all 13,364 molecular concepts and identified > 290,000 significant associations, generating hypotheses that link cancer types and subtypes, pathways, mechanisms, and drugs. To navigate a network of associations, we developed an analysis platform, the Molecular Concepts Map. We demonstrate the utility of the approach by highlighting molecular concepts analyses of Myc pathway activation, breast cancer relapse, and retinoic acid treatment.
引用
收藏
页码:443 / 454
页数:12
相关论文
共 40 条
[1]   Genetic regulators of large-scale transcriptional signatures in cancer [J].
Adler, AS ;
Lin, MH ;
Horlings, H ;
Nuyten, DSA ;
van de Vijver, MJ ;
Chang, HY .
NATURE GENETICS, 2006, 38 (04) :421-430
[2]   Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].
Bild, AH ;
Yao, G ;
Chang, JT ;
Wang, QL ;
Potti, A ;
Chasse, D ;
Joshi, MB ;
Harpole, D ;
Lancaster, JM ;
Berchuck, A ;
Olson, JA ;
Marks, JR ;
Dressman, HK ;
West, M ;
Nevins, JR .
NATURE, 2006, 439 (7074) :353-357
[3]   Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins [J].
Bouchard, C ;
Marquardt, J ;
Brás, A ;
Medema, RH ;
Eilers, M .
EMBO JOURNAL, 2004, 23 (14) :2830-2840
[4]   Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival [J].
Chang, HY ;
Nuyten, DSA ;
Sneddon, JB ;
Hastie, T ;
Tibshirani, R ;
Sorlie, T ;
Dai, HY ;
He, YDD ;
van't Veer, LJ ;
Bartelink, H ;
van de Rijn, M ;
Brown, PO ;
van de Vijver, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) :3738-3743
[5]   Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer [J].
Chang, JC ;
Wooten, EC ;
Tsimelzon, A ;
Hilsenbeck, SG ;
Gutierrez, MC ;
Elledge, R ;
Mohsin, S ;
Osborne, CK ;
Chamness, GC ;
Allred, DC ;
O'Connell, P .
LANCET, 2003, 362 (9381) :362-369
[6]   A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients [J].
Dai, HY ;
van't Veer, L ;
Lamb, J ;
He, YD ;
Mao, M ;
Fine, BM ;
Bernards, R ;
de Vijver, MV ;
Deutsch, P ;
Sachs, A ;
Stoughton, R ;
Friend, S .
CANCER RESEARCH, 2005, 65 (10) :4059-4066
[7]   Deciphering cellular states of innate tumor drug responses [J].
Graudens, E ;
Boulanger, V ;
Mollard, C ;
Mariage-Samson, R ;
Barlet, X ;
Grémy, G ;
Couillault, C ;
Lajémi, M ;
Piatier-Tonneau, D ;
Zaborski, P ;
Eveno, E ;
Auffray, C ;
Imbeaud, S .
GENOME BIOLOGY, 2006, 7 (03)
[8]   Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase [J].
Handa, H ;
Hegde, UP ;
Kotelnikov, VM ;
Mundle, SD ;
Dong, LM ;
Burke, P ;
Rose, S ;
Gaskin, F ;
Raza, A ;
Preisler, HD .
LEUKEMIA RESEARCH, 1997, 21 (06) :479-489
[9]   The Gene Ontology (GO) database and informatics resource [J].
Harris, MA ;
Clark, J ;
Ireland, A ;
Lomax, J ;
Ashburner, M ;
Foulger, R ;
Eilbeck, K ;
Lewis, S ;
Marshall, B ;
Mungall, C ;
Richter, J ;
Rubin, GM ;
Blake, JA ;
Bult, C ;
Dolan, M ;
Drabkin, H ;
Eppig, JT ;
Hill, DP ;
Ni, L ;
Ringwald, M ;
Balakrishnan, R ;
Cherry, JM ;
Christie, KR ;
Costanzo, MC ;
Dwight, SS ;
Engel, S ;
Fisk, DG ;
Hirschman, JE ;
Hong, EL ;
Nash, RS ;
Sethuraman, A ;
Theesfeld, CL ;
Botstein, D ;
Dolinski, K ;
Feierbach, B ;
Berardini, T ;
Mundodi, S ;
Rhee, SY ;
Apweiler, R ;
Barrell, D ;
Camon, E ;
Dimmer, E ;
Lee, V ;
Chisholm, R ;
Gaudet, P ;
Kibbe, W ;
Kishore, R ;
Schwarz, EM ;
Sternberg, P ;
Gwinn, M .
NUCLEIC ACIDS RESEARCH, 2004, 32 :D258-D261
[10]   Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer [J].
Hess, Kenneth R. ;
Anderson, Keith ;
Symmans, W. Fraser ;
Valero, Vicente ;
Ibrahim, Nuhad ;
Mejia, Jaime A. ;
Booser, Daniel ;
Theriault, Richard L. ;
Buzdar, Aman U. ;
Dempsey, Peter J. ;
Rouzier, Roman ;
Sneige, Nour ;
Ross, Jeffrey S. ;
Vidaurre, Tatiana ;
Gomez, Henry L. ;
Hortobagyi, Gabriel N. ;
Pusztai, Lajos .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) :4236-4244